Product Image

Huperzine A 200 mcg

Life Extension
4.6
★ ★ ★ ★ ★
(584 ratings)
Huperzine 200 mcg
Product Image
Score83
A precisely dosed, focused Huperzine A capsule may help acute attention and memory. Its potent serving and missing cycling guidance call for a cautious approach.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Mental Focus
Cognitive Support
Brain Health
Productivity Boost

Score 83

A precisely dosed, focused Huperzine A capsule may help acute attention and memory. Its potent serving and missing cycling guidance call for a cautious approach.
How scoring works
$21.81($0.36 per serving)
iHerb
$ 29.25
Pure Formulas
$ 29.25
Walmart
$ 25.49
Vitacost
$ 30.03
Amazon
$ 21.81
Report prices

Analysis

Huperzine A slows acetylcholine breakdown and may support short-term memory and attention. The 200 mcg amount is clearly disclosed and reaches the upper end of commonly used supplemental servings.

The formula is deliberately narrow, so it does not address mental energy, stress resilience, circulation, or structural brain nutrition. Evidence for routine enhancement in healthy adults is also less certain than the strong mechanism may imply.

The toothed clubmoss source is named, but extract standardization and cycling instructions are not provided. Because Huperzine A remains active for an extended period, the upper-range serving offers less flexibility for sensitive or first-time users.

Who is it for
  • Experienced users seeking targeted cholinergic support
  • People who prefer a single active cognitive ingredient
Best for
  • Short-term memory and attention support
  • Clearly disclosed Huperzine A dosing

Pros

  • Provides a precise 200 mcg active amount
  • Identifies toothed clubmoss as the source
  • Avoids unrelated filler actives

Cons

  • Upper-range serving offers limited dose flexibility
  • No cycling guidance is supplied
  • Covers only one cognitive pathway

Warnings

  • Huperzine A may cause nausea, dizziness, vivid dreams, muscle twitching, or a slowed heart rate.
  • Its long activity can allow cholinergic effects to build with frequent use.
  • Combining it with acetylcholinesterase inhibitors or other cholinergic medicines may intensify their effects.

Nutrient quality

88 Highest impact

A precise huperzine A amount from a named botanical source supports good ingredient quality. The upper-range amount and missing cycling guidance reduce suitability for continuous use.

.

Ingredient transparency

83 Highest impact

The active amount and botanical source are disclosed without a hidden blend. Extract standardization, cycling guidance, and inactive ingredients are not supplied.

.

Customer satisfaction

68 High impact

The supplied average rating is strong. A substantial rating base makes the average reasonably dependable, but no detailed experience evidence was supplied.

.

Value for money

90 Highest impact

Serving economics are favorable. Formula quality supports the asking price well.

.
Report analysis

Goals

Mental Focus
Impact
Highest effect
A- Goal FitA+ Strength of SupportC CoverageA- Formula Quality
Huperzine · 200 mcg

Huperzine A directly raises acetylcholine signaling and may support acute attention and memory. The 200 mcg amount reaches the upper end of the effective range and is clearly disclosed.

The formula is highly focused but covers only one cognitive pathway. Its long action and potent acetylcholinesterase inhibition make cycling and a cautious starting approach important, especially for people sensitive to cholinergic effects.

Study evidence
Huperzine Not classified

No linked studies yet.

Cognitive Support
Impact
Highest effect
B Goal FitA+ Strength of SupportC- CoverageA Formula Quality
Huperzine · 200 mcg

Huperzine A directly supports acetylcholine signaling and may help memory and attention. The clearly disclosed amount reaches a high-potency range in a focused capsule.

Human cognitive evidence is promising but not as robust as the strong mechanism suggests. Huperzine A may intensify effects from acetylcholinesterase inhibitors and can cause nausea, slow heart rate, or vivid dreams.

Study evidence
Huperzine Supportive 22 studies
Brain Health
Impact
Highest effect
B+ Goal FitA Strength of SupportD+ CoverageA Formula Quality
Huperzine · 200 mcg

Huperzine A directly supports acetylcholine signaling by slowing its breakdown. The 200 mcg capsule reaches the upper end of a commonly used cognitive range.

Evidence is stronger for cognitive impairment than for routine enhancement in healthy adults. The upper-range amount may increase nausea, vivid dreams, slowed heart rate, or other cholinergic effects, and no cycling guidance is provided.

Study evidence
Huperzine Supportive 17 studies
Productivity Boost
Impact
High effect
C Goal FitA Strength of SupportD CoverageA Formula Quality
Huperzine · 200 mcg

Huperzine A directly increases acetylcholine signaling and may support short-term focus or memory. Evidence for routine productivity use in healthy adults is limited, and the long-lasting action reduces flexibility.

The upper-range amount is clearly disclosed from toothed clubmoss, although extract standardization is absent. Huperzine A may cause nausea, dizziness, slow heart rate, or vivid dreams and can compound the effects of cholinergic medicines.

Study evidence
Huperzine No effect 1 study

Ingredients

IngredientAmount per serving
Huperzine A (Toothed Clubmoss extract)
200 mcg
Adults 18–50
Report overview
A+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

The capsule supplies 200 mcg Huperzine A from toothed clubmoss extract at the upper end of the effective range. Precise delivery and low cost per active amount make it efficient, though extract standardization and cycling instructions are absent. The upper-range dose may be less flexible for users who want a lower starting amount.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
    Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS; Alzheimer's Disease Cooperative Study · Neurology · 2011
    Randomized trial210 participantsCognitive Support forHuperzine
  2. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsBrain Health Productivity Boost forHuperzine
  3. Huperzine A for vascular dementia.
    Hao Z; Liu M; Liu Z; Lv D · The Cochrane database of systematic reviews · 2009
    Systematic review14 participants1 studies pooledCognitive Support forHuperzine
  4. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB · CNS drugs · 2018
    Narrative reviewBrain Health forHuperzine
  5. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  6. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  7. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsCognitive Support Brain Health forHuperzine
  8. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  9. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  10. [Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis].
    Huang P; Li B; Guo YH; Feng S; Hu J; Liu QQ · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2019
    Meta-analysis9 studies pooledBrain Health forHuperzine
  11. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.
    Wang BS; Wang H; Wei ZH; Song YY; Zhang L; Chen HZ · Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Meta-analysis4 studies pooledCognitive Support forHuperzine
  12. Huperzine A for Alzheimer's disease.
    Li J; Wu HM; Zhou RL; Liu GJ; Dong BR · The Cochrane database of systematic reviews · 2008
    Meta-analysis454 participants6 studies pooledCognitive Support forHuperzine
  13. Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.
    Zafonte RD; Fregni F; Bergin MJG; Goldstein R; Boudreau N; Monge I; Luz M; Frazier J; Giacino JT · Brain injury · 2021
    Randomized trialBrain Health forHuperzine
  14. The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews.
    Ghassab-Abdollahi N; Mobasseri K; Dehghani Ahmadabad A; Nadrian H; Mirghafourvand M · Phytotherapy research : PTR · 2021
    Systematic review6 studies pooledBrain Health forHuperzine
  15. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
    Perng CH; Chang YC; Tzang RF · Psychopharmacology · 2019
    Meta-analysis44,854 participants235 studies pooledCognitive Support forHuperzine
  16. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  17. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis.
    Cui CC; Sun Y; Wang XY; Zhang Y; Xing Y · Medicine · 2019
    Meta-analysis33 studies pooledCognitive Support forHuperzine
  18. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine